Work

Supplementary Data 3 from Inhibition of NF-κB–Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma

Year: 2023

Type: supplementary-materials

Abstract: The NF-kB inhibitor PDTC has synergistic activity with the BET inhibitor PLX51107

DOI: 10.1158/0008-5472.22423827

Authors: Grazia Ambrosini, Catherine Do, Benjamin Tycko, Ronald B. Realubit, Charles Karan, Elgilda Musi, Richard D. Carvajal, Vivian Chua, Andrew E. Aplin, Gary K. Schwartz

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361877391

Cites:

Cited by:

Related to: 10